Trichomonas vaginalis: Why we should be screening

Venereology

Volumn 14, Issue 3, 2001, Pages 116-120

  Garland, S M ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLOTRIMAZOLE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; TINIDAZOLE;

CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DOSE TIME EFFECT RELATION; DRUG COST; DRUG DOSAGE FORM; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; FETUS OUTCOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MASS SCREENING; META ANALYSIS; NONHUMAN; PARASITE CONTROL; PATHOGENESIS; PREGNANCY; PUBLIC HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; TREATMENT FAILURE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS; VIRULENCE;

EID: 0034794889     PISSN: 10321012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Alfred Francois Donné, 1801-1878, discoverer of Trichomonas vaginalis and of leukaemia
2. Description of Trichomonas vaginalis by M.A. Donné
3. Cultivation of Trichomonas from the human mouth, vagina and urine
4. Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates
5. Why is Trichomonas vaginalis ignored?
6. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia
7. Is trichomonal infestation a venereal disease?
8. Epidemiology of infections with Trichomonas vaginalis in the light of improved diagnostic methods
9. Clinical and microbiological aspects of Trichomonas vaginalis
10. Clinical manifestations of urogenital trichomoniasis in women
11. Neonatal Trichomonas vaginalis: Report of three cases and review of the literature
12. Trichomoniasis in men: Old issues and new data
13. Trichomonas vaginalis as a cause of urethritis in Malawian men
14. Structure
15. Biochemistry of Trichomonas vaginalis
16. Signalling of Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence
17. Immunology of trichomonads, with emphasis on Trichomonas vaginalis
18. Trichomonas vaginalis epidemiology: Parameterising and analysing a model of treatment interventions
19. Molecular basis of host epithelial cell recognition by Trichomonas vaginalis
20. The regulation by iron of the synthesis of adhesins and cytadherence levels in the protozoan Trichomonas vaginalis
21. Presence of laminin-binding proteins in trichomonads and their role in adhesion
22. Host plasma proteins on the surface of pathogenic Trichomonas vaginalis
23. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis
24. Activation of the alternative complement pathway by Trichomonas vaginalis
25. Iron mediates Trichomonas vaginalis resistance to complement lysis
26. Molecular analysis of Trichomonas vaginalis surface protein repertoires
27. Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis
28. Trichomonas vaginalis associated with low birth weight and preterm delivery
29. Trichomoniasis in pregnant human immunodeficiency virus-infected Congolese women: Prevalence, risk factors, and association with low birth weight
30. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis
31. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
32. Trichomonas vaginalis and amplification of HIV-1 transmission
33. Cell cultured compared with broth for detection of Trichomonas vaginalis
34. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch™ TV test
35. The tampon test for trichomoniasis: A comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women
36. An outreach programme for sexually transmitted infection screening in street sex workers using self-administered samples
37. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women
38. Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases
39. Trichomonas vaginalis: A re-emerging pathogen
40. Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis
41. In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis
42. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and resistant Giardia, Trichomonas, and Entamoeba spp